SCHEMBL23958201

SCHEMBL23958201

O=c1c2cccc(F)c2nc(Nc2cccnc2)n1-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX12 P18054 1/20 0.43
RAD52 P43351 1/20 0.42
KMT2A Q03164 1/20 0.42
PDE5A O76074 2/20 0.40
TRPV4 Q9HBA0 2/20 0.40
PDE7A Q13946 1/20 0.40
JAK1 P23458 1/20 0.40
TYK2 P29597 1/20 0.40
JAK3 P52333 1/20 0.40
MAPT P10636 2/20 0.40
MDM2 Q00987 1/20 0.39
PSD A5PKW4 1/20 0.39
LOXL3 P58215 1/20 0.39
LOXL2 Q9Y4K0 1/20 0.39
LMNA P02545 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30103287 0.88 PIK3CD (0.41) ALOX12RAD52KMT2APDE5APDE7A
SCHEMBL24111001 0.88 PIK3CD (0.41) ALOX12RAD52KMT2APDE5APDE7A
SCHEMBL23958356 0.87 ALOX12 (0.48) ALOX12RAD52KMT2APDE5APDE7A
SCHEMBL23958349 0.87 PDE7A (0.47) ALOX12RAD52KMT2APDE5APDE7A
SCHEMBL23958144 0.86 TP53 (0.44) ALOX12RAD52KMT2APDE7AJAK1
SCHEMBL23958353 0.86 TRPV4 (0.40) TRPV4MAPTLMNA
SCHEMBL23958352 0.84 G6PD (0.44) ALOX12RAD52KMT2AMAPTMDM2
SCHEMBL24110995 0.83 ALOX12 (0.57) ALOX12RAD52KMT2APDE5APDE7A
SCHEMBL24110960 0.82 PIK3CD (0.44) ALOX12RAD52KMT2AJAK1TYK2
SCHEMBL23958331 0.81 LOXL3 (0.47) ALOX12RAD52KMT2APDE5APDE7A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-12-16 US disclosed
WO-2021215537-A1 2-HETEROARYLAMINOQUINAZOLINONE DERIVATIVE 大日本住友製薬株式会社 (JP) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE CRKL, CLIC4, CLIC1 ALOX12 3240/4885RAD52 1428/4885KMT2A 1451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.